475 related articles for article (PubMed ID: 9153283)
1. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
[TBL] [Abstract][Full Text] [Related]
2. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
[TBL] [Abstract][Full Text] [Related]
3. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
[TBL] [Abstract][Full Text] [Related]
4. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS
Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
[TBL] [Abstract][Full Text] [Related]
6. Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals.
Reijonen H; Elliott JF; van Endert P; Nepom G
J Immunol; 1999 Aug; 163(3):1674-81. PubMed ID: 10415074
[TBL] [Abstract][Full Text] [Related]
7. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes.
Lohmann T; Leslie RD; Londei M
J Autoimmun; 1996 Jun; 9(3):385-9. PubMed ID: 8816975
[TBL] [Abstract][Full Text] [Related]
8. Epitopes recognized by CBV4 responding T cells: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes.
Marttila J; Hyöty H; Näntö-Salonen K; Simell O; Ilonen J
Virology; 2004 Feb; 319(1):27-35. PubMed ID: 14967485
[TBL] [Abstract][Full Text] [Related]
9. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
10. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
[TBL] [Abstract][Full Text] [Related]
11. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region.
Marttila J; Juhela S; Vaarala O; Hyöty H; Roivainen M; Hinkkanen A; Vilja P; Simell O; Ilonen J
Virology; 2001 May; 284(1):131-41. PubMed ID: 11352674
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome.
Skorstad G; Hestvik AL; Vartdal F; Holmøy T
J Autoimmun; 2009 Feb; 32(1):24-32. PubMed ID: 19027267
[TBL] [Abstract][Full Text] [Related]
13. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
14. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
15. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
16. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
Quinn A; Sercarz EE
J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
de Koster HS; van Rood JJ; Termijtelen A
Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
[TBL] [Abstract][Full Text] [Related]
18. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.
Schloot NC; Willemen S; Duinkerken G; de Vries RR; Roep BO
J Autoimmun; 1998 Apr; 11(2):169-75. PubMed ID: 9650096
[TBL] [Abstract][Full Text] [Related]
19. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
[TBL] [Abstract][Full Text] [Related]
20. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]